Shares of ride sharing leader Uber Technologies, Inc. (UBER) are up 13% since Big Money first bought big in May.

Rocket Pharmaceuticals said on Friday that it has withdrawn its application for U.S approval of its experimental gene therapy for a rare inherited blood disorder.

Many investors look at Palantir Technologies Inc. NASDAQ: PLTR and wish they had had the insight to start buying before the rest of the market caught on to this stock, driving its price higher by over 1,800% during the past five years.

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In National Grid (NGG) To Contact Him Directly To Discuss Their Options If you purchased or acquired stock in National Grid and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Marion Passmore directly at (212) 355-4648.

NEW YORK--(BUSINESS WIRE)-- #mcb--Metropolitan Commercial Bank (the “Bank,” “MCB”), a full-service commercial bank headquartered in New York City, is proud to announce it has been recognized with the 2025 WebAward for Bank Standard of Excellence by the Web Marketing Association (WMA). This prestigious award highlights the Bank's commitment to deliver an exceptional digital experience that reflects both innovation and a client-first approach. The "Bank Standard of Excellence Award" is an honor given by.

Initial closing of approximately $81 million expected to fund current operating plan and clinical pipeline into 2028, with potential for up to $94 million in additional proceeds upon exercise of issued warrants Initial closing of approximately $81 million expected to fund current operating plan and clinical pipeline into 2028, with potential for up to $94 million in additional proceeds upon exercise of issued warrants

FREDERICK, Md., Oct. 03, 2025 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a clinical-stage biotechnology company pioneering cell therapy for autoimmune diseases, today announced the granting of an inducement award to one new employee. On October 2, 2025, the Company issued to this employee an option to purchase an aggregate of 9,700 shares of the Company's common stock with an exercise price of $10.34, the closing trading price of the Company's common stock on the Nasdaq Global Market on the date of grant. The option was granted pursuant to the Company's Amended and Restated 2018 Employment Inducement …

I detail what type of dividend investments are ideal for retiring on dividends. I list 3 excellent candidates to build a portfolio that can potentially pay your bills forever. I also share some of the risks to keep in mind.

It's been a bloodbath for the quantum computing stocks in the last few sessions.

Proceeds to be Used to Accelerate the Development of the United States Uranium Refining & Conversion Corp CORPUS CHRISTI, Texas , Oct. 3, 2025 /PRNewswire/ - Uranium Energy Corp. (NYSE American: UEC, the "Company" or "UEC") announced today the launch of a public offering of 15,500,000 shares of its common stock (the "Offering"). In connection with the Offering, the Company intends to grant to the underwriter a 30-day option to purchase up to an additional 2,325,000 shares of its common stock.

OnePay, the fintech firm majority-owned by Walmart, will soon offer cryptocurrency trading and custody on its mobile app, CNBC has learned. OnePay will offer customers access to bitcoin and ether later this year with help from the startup Zerohash.

DUBLIN , Oct. 3, 2025 /PRNewswire/ -- AerCap Holdings N.V. ("AerCap") (NYSE: AER) has announced its major business transactions during the third quarter 2025: Signed 66 lease agreements, including 14 widebody aircraft, 25 narrowbody aircraft, 15 engines and 12 helicopters.

FRAMINGHAM, Mass. & SALISBURY, England--(BUSINESS WIRE)--KalVista Pharmaceuticals, Inc. (Nasdaq: KALV), today announced that the compensation committee of KalVista's board of directors granted two newly-hired employees inducement options to purchase an aggregate of 30,000 shares of KalVista common stock on October 1, 2025 as inducements material to each employee entering into employment with KalVista. The options have an exercise price that is equal to the closing price of KalVista common stock.

CHICAGO--(BUSINESS WIRE)--Byline Bancorp, Inc. (NYSE: BY) announced today that it will issue its third quarter 2025 financial results after market close on Thursday, October 23, 2025. Byline Bancorp will also host a conference call and webcast at 9:00 a.m. Central Time on Friday, October 24, 2025 to discuss its financial results. Analysts and investors may participate in the question-and-answer session. Conference Call, Replay and Webcast Information: Date: Friday, October 24, 2025 Time: 9:00 a.

BILLERICA, Mass.--(BUSINESS WIRE)---- $BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) today announced new orders for advanced Nuclear Magnetic Resonance (NMR) instrumentation from the New York Structural Biology Center (NYSBC), the University of Delaware and Northwestern University. Supported by the National Institutes of Health (NIH) and the National Science Foundation (NSF), these high-performance systems will enable leading research teams to pursue breakthroughs across a wide range of scientific research, dr.

NEW YORK, Oct. 03, 2025 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (Nasdaq: OVID), a biopharmaceutical company dedicated to developing small molecule medicines for brain conditions with significant unmet need, today announced positive topline results from its Phase 1 healthy volunteer study evaluating the safety, tolerability, pharmacokinetic (PK) and pharmacodynamic (PD) activity of OV329, a next generation GABA-aminotransferase (GABA-AT) inhibitor being developed for drug-resistant epilepsies.

BROOKFIELD, News, Oct. 03, 2025 (GLOBE NEWSWIRE) -- Brookfield Renewable (NYSE: BEP, BEPC; TSX: BEP.UN, BEPC) (“Brookfield Renewable”) will hold its Third Quarter 2025 Conference Call and Webcast on Wednesday, November 5, 2025 at 9:00 a.m. ET to discuss results and business initiatives.

RESEARCH TRIANGLE PARK, N.C., Oct. 03, 2025 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the compensation committee of BioCryst's board of directors granted eight newly-hired employees stock options to purchase an aggregate of 115,000 shares, and restricted stock units (RSUs) covering an aggregate of 91,450 shares, of BioCryst common stock. The options and RSUs were granted as of October 1, 2025, as inducements material to each employee entering into employment with BioCryst. The options and RSUs were granted in accordance with Nasdaq Listing Rule 5635(c)(4).

TORONTO, Oct. 03, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“Quantum BioPharma” or the “Company”), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, announced today that its Board of Directors has established October 27, 2025 as the record date for the distribution of contingent value rights (“CVRs”) to holders of its Class B Subordinate Voting Shares on a one-for-one basis, advancing the Company's previously disclosed plan in the Company's press release dated June 13, 2025, to deliver a litigation-linked CVR to shareholders of record as of the record …

~ Bold 2026 strategy targets game-changing acquisitions and new revenue streams ~ ~ Aggressive M&A strategy designed to accelerate growth ~